Back to UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

SPRYSPRY
14 quarters

Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCUBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in ARS PHARMACEUTICALS INC

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 461,384 shares of SPRY (ARS PHARMACEUTICALS INC), worth $3.7M as of 2026-Q2. The position was decreased (-0.7% shares). SPRY represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.

Current Value

$3.7M

Current Shares

461,384

Total Value Change

+$1M

Total Shares Change

+403,809

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
461,384
-0.7%
$3.7M0.0%$8.01
0
2026-Q1
Increased
464,681
+52.6%
$3.7M0.0%$8.87
37
2025-Q4
Decreased
304,445
-9.2%
$3.5M0.0%$11.64
0
2025-Q3
Increased
335,148
+2.9%
$3.4M0.0%$9.72
27
2025-Q2
Increased
325,645
+16.4%
$5.7M0.0%$18.20
31
2025-Q1
Increased
279,840
+13.2%
$3.5M0.0%$12.49
30
2024-Q4
Increased
247,314
+5.5%
$2.6M0.0%$10.62
28
2024-Q3
Increased
234,537
+766.1%
$3.4M0.0%$14.32
43
2024-Q2
Increased
27,081
+109.3%
$230,4590.0%$8.51
37
2024-Q1
Unchanged
12,940
0.0%
$132,2470.0%$10.22
0
2023-Q4
Unchanged
12,940
0.0%
$70,9110.0%$5.48
0
2023-Q3
New
12,940
-
$48,9130.0%$3.78
31
2021-Q1
Exited
0
-100.0%
$00.0%$40.57
0
2020-Q4
New
57,575
-
$2.7M0.0%$42.04
36

Other major holders of SPRY: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used